The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -16.30%.However, over the last six months, we can see a stronger performance of -2.88%. Over the last 30 days, the price of ATYR has fallen by 0.66%. And in the last five days, it has fallen by -4.11%.
Atyr Pharma Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $4.66 on 02/21/25 and the lowest value was $1.42 on 06/21/24.
52-week price history of ATYR Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Atyr Pharma Inc’s current trading price is -34.98% away from its 52-week high, while its distance from the 52-week low is 113.38%. The stock’s price range during this period has varied between$1.42 and $4.66. The Atyr Pharma Inc’s shares, which operate in the Healthcare, saw a trading volume of around 2.01 million for the day, a figure considerably higher than their average daily volume of 1.53 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Atyr Pharma Inc (ATYR) has experienced a quarterly decline of -15.83% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 269.68M and boasts a workforce of 59 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.48, with a change in price of -0.05. Similarly, Atyr Pharma Inc recorded 1,276,193 in trading volume during the last 100 days, posting a change of -1.62%.
ATYR’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ATYR stands at 0.17. Similarly, the long-term debt-to-equity ratio is also 0.16.
ATYR Stock Stochastic Average
Atyr Pharma Inc’s raw stochastic average for the past 50 days is presently 36.14%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 21.95%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 41.87% and 51.01%, respectively.
